We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
-20.52%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$220M
AUM Growth
-$141M
(-39%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-34.5%
Top 10 Holdings %
Top 10 Hldgs %
7.96%
Holding
421
New
120
Increased
25
Reduced
138
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$1.94M |
| 2 |
BERY
Berry Global Group, Inc.
BERY
|
+$1.81M |
| 3 |
TransUnion
TRU
|
+$1.79M |
| 4 |
RenaissanceRe
RNR
|
+$1.76M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.21M |
| 2 |
PACCAR
PCAR
|
+$2.16M |
| 3 |
Spotify
SPOT
|
+$2.12M |
| 4 |
US Foods
USFD
|
+$2.06M |
| 5 |
ONE Gas
OGS
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.83% |
| 2 | Healthcare | 15.4% |
| 3 | Industrials | 12.81% |
| 4 | Financials | 12.39% |
| 5 | Real Estate | 6.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XRN
126
Chiron Real Estate Inc
XRN
$516M
| $752K | 0.34% |
+14,854
| New | +$1,000K |
|
127
Integer Holdings
ITGR
$3.42B
| $751K | 0.34% |
11,954
-2,835
| -19% | -$231K |
|
|
MODN
128
DELISTED
MODEL N, INC.
MODN
| $750K | 0.34% |
+33,771
| New | +$987K |
|
129
HCA Healthcare
HCA
$85.7B
| $748K | 0.34% |
8,330
+2,147
| +35% | +$278K |
|
130
Match Group
MTCH
$9.17B
| $748K | 0.34% |
+11,330
| New | +$833K |
|
131
NRG Energy
NRG
$28.3B
| $746K | 0.34% |
27,349
-4,730
| -15% | -$163K |
|
132
Innovative Industrial Properties
IIPR
$1.76B
| $742K | 0.34% |
9,775
-2,321
| -19% | -$196K |
|
|
SYKE
133
DELISTED
SYKES Enterprises Inc
SYKE
| $738K | 0.34% |
+27,195
| New | +$877K |
|
|
RCM
134
DELISTED
R1 RCM Inc. Common Stock
RCM
| $737K | 0.33% |
+81,080
| New | +$975K |
|
135
Castle Biosciences
CSTL
$813M
| $733K | 0.33% |
+24,581
| New | +$742K |
|
136
TTEC Holdings
TTEC
$126M
| $728K | 0.33% |
+19,835
| New | +$771K |
|
|
NUVA
137
DELISTED
NuVasive, Inc.
NUVA
| $725K | 0.33% |
14,320
-14,057
| -50% | -$943K |
|
138
Pacira BioSciences
PCRX
$1.06B
| $724K | 0.33% |
+21,602
| New | +$897K |
|
139
Columbia Banking Systems
COLB
$8.84B
| $723K | 0.33% |
+26,972
| New | +$948K |
|
140
Tactile Systems Technology
TCMD
$636M
| $722K | 0.33% |
+17,973
| New | +$963K |
|
|
TXNM
141
TXNM Energy Inc
TXNM
$6.42B
| $718K | 0.33% |
+18,885
| New | +$915K |
|
142
BlackLine
BL
$1.8B
| $716K | 0.33% |
13,612
-10,173
| -43% | -$595K |
|
|
REGI
143
DELISTED
Renewable Energy Group, Inc.
REGI
| $716K | 0.33% |
+34,879
| New | +$883K |
|
144
Collegium Pharmaceutical
COLL
$1.17B
| $713K | 0.32% |
+43,663
| New | +$901K |
|
145
Health Catalyst
HCAT
$154M
| $713K | 0.32% |
+27,282
| New | +$834K |
|
146
Pricesmart
PSMT
$5.94B
| $711K | 0.32% |
13,524
-3,208
| -19% | -$187K |
|
|
GMS
147
DELISTED
GMS Inc
GMS
| $710K | 0.32% |
+45,113
| New | +$1.07M |
|
148
Clearwater Paper
CLW
$341M
| $709K | 0.32% |
+32,512
| New | +$782K |
|
149
EverQuote
EVER
$886M
| $709K | 0.32% |
27,026
-18,258
| -40% | -$643K |
|
150
Installed Building Products
IBP
$6.07B
| $709K | 0.32% |
17,782
-5,167
| -23% | -$334K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q1 2020 Portfolio in Review
As of Q1 2020, 361 Capital held 421 positions worth $220M, down 39% from $361M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
361 Capital withdrew a net $75.9M in Q1 2020, closing 136 positions and reducing 138 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $2.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 361 Capital opened a new position in Williams Companies worth $1.42M.
- 361 Capital's largest Q1 2020 buy was Williams Companies: 100,317 shares worth $1.42M.
- 361 Capital added most to Huntington Ingalls Industries in Q1 2020, an estimated $1.2M increase.
- 361 Capital's biggest Q1 2020 reduction was Zebra Technologies, cutting an estimated $1.52M.
- 361 Capital fully exited Jazz Pharmaceuticals in Q1 2020, selling an estimated $2.21M.
- 361 Capital's ten largest holdings make up 8% of its $220M portfolio in Q1 2020.
- 361 Capital opened 120 new positions and closed 136 in Q1 2020.
- 361 Capital's portfolio value fell 39% quarter-over-quarter to $220M.
Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.